Tuesday, June 18, 2013
Eli Lilly studying deaths of two patients on long-acting Zyprexa
(Reuters) - The Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for schizophrenia, called Zyprexa Relprevv.
The agency said the patients died 3 to 4 days after receiving an appropriate dose of the medicine.
(Reporting by Ransdell Pierson; Editing by Gerald E. McCormick)
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends: 'You Say What You Like, Because They Like What You Say' - http://www.medialens.org/index.php/alerts/alert-archive/alerts-2013/731-you-say-what-you-like-because-they-like-what-you-say.html
